Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.PolyMedix, a biotechnology company engaged in the development of acute care products for infectious diseases and acute cardiovascular disorders based on biomimetics, has appointed Gregory Ford as its new vice president of business development.
Subscribe to our email newsletter
Mr Ford has over 20 years of experience at both biotechnology as well as major pharmaceutical companies. Mr Ford was most recently vice president of business development at CollaGenex Pharmaceuticals.
He has previously worked at Skye Pharma, RTP Pharma, Boehringer-Ingelheim, and Mylan Laboratories and holds a BS in industrial engineering and an MBA degree from West Virginia University.